A 65-year-old man with prior NSTEMI and coronary stent placement 2 years ago is adherent to high-intensity statin therapy but his LDL-C remains 2.4 mm...

Question

A 65-year-old man with prior NSTEMI and coronary stent placement 2 years ago is adherent to high-intensity statin therapy but his LDL-C remains 2.4 mmol/L despite excellent lifestyle measures. According to CCS lipids guidance, what is the next best step to further reduce his cardiovascular risk?

Accepted Answer

Add ezetimibe to his current high-intensity statin

Answer

Switch to low-intensity statin plus fibrate

Answer

Stop statin and start PCSK9 inhibitor monotherapy

Answer

Add niacin to his regimen

Answer

No change; LDL is acceptable for secondary prevention

ca-mccqe1 MCQ (SBA): Secondary prevention dyslipidaemia

A 65-year-old man with prior NSTEMI and coronary stent placement 2 years ago is adherent to high-intensity statin therapy but his LDL-C remains 2.4 mmol/L despite excellent lifestyle measures. According to CCS lipids guidance, what is the next best step to further reduce his cardiovascular risk?